Promising and Minimally Invasive Biomarkers: Targeting Melanoma
Article in Cells (December 2023)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
The Predictive Value of FDG PET/CT for Determining Progression-Free Survival in Advanced Stage III–IV BRAF-Mutated Melanoma Patients Treated With Targeted Therapy—What Can Be Learned From Progression?
Article in Clinical Nuclear Medicine (December 2023)
Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review
Article in Journal of Cannabis Research (March 2022)